{"nct_id":"NCT02177721","title":"Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario","status":"NOT_YET_RECRUITING","status_verified_date":"2025-07","start_date":"2026-05","start_date_type":"ESTIMATED","primary_completion_date":"2035-05","primary_completion_date_type":"ESTIMATED","completion_date":"2035-12","completion_date_type":"ESTIMATED","phases":["PHASE4"],"tickers":["EBS"]}